{
    "organizations": [],
    "uuid": "14a2652f3006045834a5bb1f2db47aa72ded883c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-verastem-oncology-reports-q1-loss/brief-verastem-oncology-reports-q1-loss-per-share-of-0-41-idUSASC09ZNP",
    "ord_in_thread": 0,
    "title": "Verastem Oncology Reports Q1 Loss Per Share Of $0.41",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Verastem Inc:\n* VERASTEM ONCOLOGY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 LOSS PER SHARE $0.41 * Q1 EARNINGS PER SHARE VIEW $-0.39 â€” THOMSON REUTERS I/B/E/S\n* EXPECTS TO HAVE SUFFICIENT CASH AND CASH EQUIVALENTS TO FUND OPERATIONS INTO 2019 Source text for Eikon:\nOur ",
    "published": "2018-05-04T04:20:00.000+03:00",
    "crawled": "2018-05-04T17:21:27.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "verastem",
        "inc",
        "verastem",
        "oncology",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "expects",
        "sufficient",
        "cash",
        "cash",
        "equivalent",
        "fund",
        "operation",
        "source",
        "text",
        "eikon"
    ]
}